LivaNova (LIVN) Total Debt Growth (5y) (2020 - 2026)
LivaNova (LIVN) Total Debt Growth (5y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.91 Bn | 193.31 Bn | 7.27 Bn |
| 2 | Stryker | 127.59 Bn | 124.11 Bn | 4.50 Bn |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.24 Bn | 72.70 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn |
| 6 | Dexcom | 34.38 Bn | 32.44 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.96 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn |
| 9 | Steris | 23.08 Bn | 22.60 Bn | 684.20 Mn |
| 10 | LivaNova | 4.29 Bn | 3.77 Bn | 273.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -19.89% |
| Mar 31, 2026 | -15.24% |
| Dec 31, 2025 | -8.49% |
| Sep 30, 2025 | -7.77% |
| Jun 30, 2025 | -8.64% |
| Mar 31, 2025 | 5.60% |
| Dec 31, 2024 | 15.86% |
| Sep 30, 2024 | 9.69% |
| Jun 30, 2024 | 24.13% |
| Mar 31, 2024 | 28.06% |
| Dec 31, 2023 | 29.12% |
| Sep 30, 2023 | 30.18% |
| Jun 30, 2023 | 30.33% |
| Mar 31, 2023 | 25.20% |
| Dec 31, 2022 | 29.97% |
| Sep 30, 2022 | 35.15% |
| Jun 30, 2022 | 30.00% |
| Mar 31, 2022 | 30.63% |
| Dec 31, 2021 | 30.58% |
| Sep 30, 2021 | 26.17% |